CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 77 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-04-28 | ACC International Holdings Ltd. Member of 10% owner group | Purchase | +939,600 | $0.30 | $282K | 1,239,600 |
| 2014-04-13 | Israeli Avi Director | Grant or award · Stock Option (right to buy) | +166,666 | 166,666 | ||
| 2014-04-13 | Israeli Avi Director | Grant or award · Stock Option (right to buy) | +133,334 | 133,334 | ||
| 2013-12-31 | Sossover Liat Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2013-04-19 | TAUB MALCOLM S Director | Grant or award | +130,000 | 498,333 | ||
| 2013-04-19 | Friedman Mordechai Director | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2013-04-19 | Pinkas Alon Director | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2013-04-19 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2013-04-19 | SHORR ROBERT G L Director | Grant or award | +130,000 | 490,000 | ||
| 2013-04-13 | Israeli Avi Director | Grant or award · Stock Option (right to buy) | +166,666 | 166,666 | ||
| 2012-08-01 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2012-08-01 | Pinkas Alon Director | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2012-08-01 | Friedman Mordechai Director | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2012-08-01 | Sossover Liat Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2012-08-01 | Harel Adrian Chief Executive Officer | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2012-08-01 | Harel Adrian Chief Executive Officer | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2012-08-01 | Sossover Liat Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2012-08-01 | SHORR ROBERT G L Director | Grant or award | +130,000 | 360,000 | ||
| 2012-08-01 | TAUB MALCOLM S Director | Grant or award | +130,000 | 368,333 | ||
| 2012-04-13 | Israeli Avi Director | Grant or award · Stock Option (right to buy) | +166,666 | 166,666 |
Page 13 of 14 · 274 trades